Stay updated on Roxadustat Efficiency & Safety in Anemia of Lower Risk MDS Clinical Trial
Sign up to get notified when there's something new on the Roxadustat Efficiency & Safety in Anemia of Lower Risk MDS Clinical Trial page.

Latest updates to the Roxadustat Efficiency & Safety in Anemia of Lower Risk MDS Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov page displays the study record for the roxadustat Phase 3 trial, including its design, eligibility criteria, locations, outcome measures, and posted results. The record states that the study was terminated because it did not meet its primary efficacy endpoint and is no longer recruiting.SummaryDifference100%

- Check9 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check16 days agoChange DetectedA banner announces NIH’s website transition and says that “Super Intelligence” is replacing “Artificial Intelligence” in some agency content.SummaryDifference1%

- Check23 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check44 days agoChange DetectedThe page previously showed a 403 error; the HTML for that error page and the Home link were removed, yielding a standard layout for the page.SummaryDifference0.5%

Stay in the know with updates to Roxadustat Efficiency & Safety in Anemia of Lower Risk MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roxadustat Efficiency & Safety in Anemia of Lower Risk MDS Clinical Trial page.